Trial Profile
Stage III clinical research plan for effectiveness and safety of Mycobacterium vaccae for Injection (Vaccae) applying in high-risk groups to prevent the tuberculosis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Mycobacterium vaccae vaccine (Primary)
- Indications Tuberculosis
- Focus Registrational; Therapeutic Use
- Sponsors AnHui Longcom Biologic Pharmacy
- 15 May 2016 Status changed from recruiting to completed.
- 26 Nov 2013 New trial record